Peter Gowland
Impact in
- Virology top 5%
- HIV Research and Treatment
- Hepatology top 10%
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 7
- COVID-19 Clinical Research Studies 4
- Epidemiology 10
- Hepatitis B Virus Studies 9
- Co-authors
- Christoph Niederhauser (27 shared papers)Caroline Tinguely (13 shared papers)Stefano Fontana (11 shared papers)Behrouz Mansouri Taleghani (3 shared papers)Hein Hustinx (6 shared papers)Christian Ruef (1 shared paper)Florian Strasser (1 shared paper)Richard W. Cone (1 shared paper)
- Journals
- Transfusion (4 papers)Viruses (3 papers)Vox Sanguinis (3 papers)Antiviral chemistry & chemotherapy (2 papers)Journal of Medical Virology (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Peter Gowland
33 papers receiving 396 citations
Peers
Comparison fields: 5 of 59
- Virology 81
- Hepatology 111
- Hematology 109
- Infectious Diseases 160
- Management of Technology and Innovation 27
Countries citing papers authored by Peter Gowland
This map shows the geographic impact of Peter Gowland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gowland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gowland more than expected).
Fields of papers citing papers by Peter Gowland
This network shows the impact of papers produced by Peter Gowland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gowland. The network helps show where Peter Gowland may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Gowland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 37 | |
| 2 | 1994 | 32 | |
| 3 | 1998 | 32 | |
| 4 | 2004 | 31 | |
| 5 | 2014 | 31 | |
| 6 | 2010 | 24 | |
| 7 | 1997 | 22 | |
| 8 | 2010 | 18 | |
| 9 | 2006 | 17 | |
| 10 | 2016 | 16 | |
| 11 | 2014 | 16 | |
| 12 | 1994 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 1995 | 10 | |
| 16 | 2008 | 9 | |
| 17 | 1994 | 9 | |
| 18 | 2013 | 8 | |
| 19 | 2021 | 6 | |
| 20 | 2019 | 6 |
About Peter Gowland
Peter Gowland is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Virology and Hematology, having authored 36 papers that have together received 404 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), HIV Research and Treatment (7 papers), Blood groups and transfusion (7 papers), HIV/AIDS drug development and treatment (7 papers), Hepatitis Viruses Studies and Epidemiology (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Hepatitis C virus research (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (81 citations), Hepatology (111 citations), Hematology (109 citations), Infectious Diseases (160 citations) and Management of Technology and Innovation (27 citations). Peter Gowland has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Christoph Niederhauser, Caroline Tinguely, Stefano Fontana, Behrouz Mansouri Taleghani, Hein Hustinx, Christian Ruef, Florian Strasser, Richard W. Cone, Milos Opravil and Peter J. Grob. Their work appears in journals such as Transfusion, Viruses, Vox Sanguinis, Antiviral chemistry & chemotherapy and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.